Abstract
BACKGROUND CONTEXT: Patients treated with topical bovine thrombin preparations may develop antibodies directed against bovine coagulation factors that can cross-react with human endogenous coagulation proteins and lead to alterations in coagulation laboratory parameters or in some cases to severe bleeding or thrombosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
